Chronic Heart Failure Shows Improvement with Stem Cell Therapy… 'New Hope' for Heart Disease Treatment

The


heart receives oxygen and nutrients from three coronary arteries and beats accordingly. If any one of these arteries becomes acutely blocked due to a blood clot or sudden vasoconstriction, the supply of oxygen and nutrients to the heart is drastically reduced, causing the tissue and cells of the heart muscle to undergo necrosis. This is known as a myocardial infarction. As of 2018, there were 110,773 cases of myocardial infarction, with a mortality rate of 62.4 per 100,000 people, and the number of cases is on the rise each year.


Until now, there has been no breakthrough method to regenerate the dead heart muscle tissue and cells following a myocardial infarction. However, research and treatments using stem cells to regenerate heart muscle are ongoing in Korea, the United States, Europe, and elsewhere. Among these efforts, Kim Hyun-soo Internal Medicine Clinic—a domestic stem cell hospital—has reported numerous cases of successful treatment for myocardial infarction and chronic heart failure using stem cells, offering new hope to patients suffering from heart disease.

Mr. K, who suffered from chronic heart failure, had undergone a stent implantation procedure for angina 17 years ago. Although he had strictly adhered to his medication regimen and consistently performed aerobic exercise every morning since then, he was unable to lead a normal life due to intense chest pain and overwhelming shortness of breath. After learning through an acquaintance that stem cells could be used to treat chronic heart failure, he began his first stem cell therapy in the fall of 2018. Since then, the chronic chest pain and shortness of breath that had persisted for over a decade have gradually disappeared, and he has seen improvements not only in his ability to hike but also in his fatigue and insomnia.

Dr. Kim Hyun-soo, Director of Kim Hyun-soo Internal Medicine Clinic—a research-focused stem cell hospital—stated, stated, “This is a representative case where, in addition to the treatment of chronic heart failure, we were able to observe so-called anti-aging effects through the regenerative effects—the core principle of stem cell therapy,” adding that he hopes stem cell therapy will become a standardized treatment method for patients with chronic heart failure in the future.

Located in Gangnam, Kim Hyun-soo Internal Medicine Clinic is a stem cell clinic established based on PamiCell’s technological expertise. Building on this foundation, the clinic provides stem cell treatments not only for heart diseases such as acute myocardial infarction, ischemic cardiomyopathy, and heart failure, but also for numerous intractable diseases including cirrhosis, stroke, Parkinson’s disease, and spinal cord injury. 

Meanwhile, since the results of procedures and treatments using stem cells may vary depending on the patient’s constitution, treatment should be pursued only after consulting with a specialist.